Skip to main content

Table 1 Association between LBX2-AS1 protein expression and clinicopathologic characteristics of 265 CRC patients in the study cohort

From: RETRACTED ARTICLE: LncRNA LBX2-AS1 promotes colorectal cancer progression and 5-fluorouracil resistance

Characteristics

No.of

LBX2-AS1 protein level

P value

Patient

High (N = 135)

Low (N = 130)

Gender

0.182

 Female

117

65

52

 

 Male

148

70

78

 

Age (years)

0.641

 < 60

76

37

39

 

 ≥ 60

189

98

91

 

Tumor location

0.441

 Rectum

118

57

61

 

 Colon

147

78

69

 

Differentiation grade

0.330

 Well + moderate

201

99

102

 

 Poor

64

36

28

 

Tumor size (cm)

0.259

 < 5

105

49

56

 

 ≥ 5

160

86

74

 

Local invasion

0.014

 pT1–T2

201

95

116

 

 pT3–T4

64

40

24

 

Lymph node metastasis

0.031

 N0 + N1

164

75

89

 

 N2

101

60

41

 

TNM stage

0.017

 I + II

158

71

87

 

 III

107

64

43

 

Adjuvant chemotherapy

0.245

 No

76

43

33

 

 Yes

189

92

97

 

CA19-9(kU/L)

0.251

 < 40

123

58

65

 

 ≥ 40

142

77

65

 

Serum CEA level (ng/mL)

0.730

 < 10

117

61

56

 

 ≥ 10

148

74

74

 
  1. Bold type indicates statistical significance